Our findings indicated that TMED2 knockdown significantly inhibited the development of LUAD by increasing apoptosis, inhibiting tumor cell proliferation, reducing tumor volume, and decreasing the levels of tumor biomarkers and inflammatory factors by affecting the TLR4/NF-κB signaling pathway. This evidence concerns the gene TMED2 and neoplasm.